|
DARS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.11659999977054E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.72700000025772E-07 |
| Normal-vs-Stage2 |
1.192800E-01 |
| Normal-vs-Stage3 |
2.93780000004684E-06 |
| Normal-vs-Stage4 |
1.142750E-03 |
| Stage1-vs-Stage2 |
1.166600E-01 |
| Stage1-vs-Stage3 |
8.184200E-01 |
| Stage1-vs-Stage4 |
7.595200E-01 |
| Stage2-vs-Stage3 |
1.125970E-01 |
| Stage2-vs-Stage4 |
2.617000E-01 |
| Stage3-vs-Stage4 |
6.775800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.68050000032483E-07 |
| Normal-vs-AfricanAmerican |
1.927520E-02 |
| Normal-vs-Asian |
9.93320000000075E-05 |
| Caucasian-vs-AfricanAmerican |
4.188400E-01 |
| Caucasian-vs-Asian |
8.252600E-01 |
| AfricanAmerican-vs-Asian |
3.476800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.15639999999939E-05 |
| Normal-vs-Female |
3.15169999998144E-06 |
| Male-vs-Female |
7.550000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.64559999977266E-07 |
| Normal-vs-Age(41-60Yrs) |
1.22280000003361E-06 |
| Normal-vs-Age(61-80Yrs) |
2.679500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.912400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.346800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.695600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.104400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.810200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.739200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.059000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.267400E-01 |
| Classical-VS-Follicular |
7.789200E-01 |
| Classical-VS-Other |
1.538800E-01 |
| Classical-VS-Normal |
3.62679999998949E-06 |
| Tall-VS-Follicular |
4.156600E-01 |
| Tall-VS-Other |
9.967700E-02 |
| Tall-VS-Normal |
6.28919999999811E-05 |
| Follicular-VS-Other |
1.886750E-01 |
| Follicular-VS-Normal |
9.215400E-04 |
| Other-VS-Normal |
4.223700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76509999949559E-07 |
| Normal-vs-N1 |
3.53450000045719E-07 |
| N0-vs-N1 |
2.399000E-01 |
|
|
